Cover Image

Should acellular pertussis vaccine be recommended to healthcare professionals?

Show other versions (1)

The aim of this study was to describe recent changes in the epidemiology of pertussis and existing policies regarding recommended and mandatory occupational vaccinations for healthcare professionals (HCPs). The authors carried out an extensive review of references on the PubMed and SciELO databases...

Full description

Saved in:

Bibliographic Details
Main Authors:	José Cassio de Moraes (Author), Telma Carvalhanas (Author), Lucia Ferro Bricks (Author)
Format:	Book
Published:	Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2013-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Should acellular pertussis vaccine be recommended to healthcare professionals?
by: José Cassio de Moraes, et al.

Vacina acelular contra pertússis para adolescentes Acellular pertussis vaccine for adolescents
by: Aroldo P. de Carvalho, et al.
Published: (2006)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008)

Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives
by: Marieke Hoonakker, et al.
Published: (2017)

Choosing from Whole Cell and Acellular Pertussis Vaccines- Dilemma for the Developing Countries
by: Muhammad Ali SYED
Published: (2017)

Use of acellular pertussis vaccines in the United States: can we do better?
by: Nicola P. Klein, et al.
Published: (2017)

Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule?
by: Abdoulreza Esteghamati, et al.
Published: (2021)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
by: Geert Leroux-Roels, et al.
Published: (2018)

Risk of Brain Damage Following Pertussis Immunization with Whole-Cell cf Acellular Vaccines
by: J Gordon Millichap
Published: (2004)

Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama
by: Arlene E. Calvo, et al.
Published: (2024)

Predictors of Tetanus-Diphtheria- Acellular Pertussis Vaccination Among Adults Receiving Tetanus Vaccine in the United States
by: Tracy L. Johns, et al.
Published: (2013)

Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness
by: Ousseny Zerbo, et al.
Published: (2022)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
by: Hye-Kyung Cho, et al.
Published: (2021)

Attitudes of US Obstetricians Toward a Combined Tetanus-Diphtheria-Acellular Pertussis Vaccine for Adults
by: Sarah J. Clark, et al.
Published: (2006)

How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile?
by: Francisca Aguirre-Boza, et al.
Published: (2021)

Factors associated with receipt of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) in mothers who deliver preterm
by: Shetal I. Shah, et al.
Published: (2023)

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016-2019
by: Cheryl J. Isenhour, DVM, et al.
Published: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
by: Peter Van den Steen, et al.
Published: (2023)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
by: Chukiat Sirivichayakul, et al.
Published: (2017)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011)

Indicação de vacinas e imunoglobulinas em indivíduos que apresentam comprometimento da imunidade Recommendations on immunization of patients with conditions associated with general or limited immunodeficiencies
by: Lucia Ferro Bricks
Published: (1998)

Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage
by: Janice Seinfeld, et al.
Published: (2024)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023)

Uso universal da vacina inativada contra poliomielite Universal use of inactivated polio vaccine
by: Lucia Ferro Bricks
Published: (2006)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
by: Meichen Pan, et al.
Published: (2023)

Knowledge and attitude factors associated with the prevalence of Tdap (tetanus, diphtheria, and acellular pertussis) booster vaccination in healthcare workers in a large academic hospital in Southern Italy in 2022: a cross-sectional study
by: Michelangelo Mercogliano, et al.
Published: (2023)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
by: Yoshiyuki Tanaka, et al.
Published: (2017)

Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India
by: Pierre Bakhache, et al.
Published: (2022)

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
by: Charlotte Switzer, et al.
Published: (2021)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
by: Soon Min Lee, et al.
Published: (2019)

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study
by: Melina Thibault, et al.
Published: (2024)

Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis
by: Julianne Bayliss, et al.
Published: (2021)

Serum sickness-like reaction after diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b conjugate (5-in-1 vaccine) vaccination: A case report
by: Wei-Yu Chen, et al.
Published: (2020)

Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study
by: Tony Antoniou, et al.
Published: (2023)

Hepatitis B Response of Premature Infants after Primary and Booster Immunisation with a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Poliovirus/Haemophilus Influenzae Type B Vaccine
by: Felix Omeñaca, et al.
Published: (2010)

Impacto da vacina conjugada contra Streptococcus pneumoniae em doenças invasivas Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases
by: Lucia Ferro Bricks, et al.
Published: (2006)

Pertussis, anti-Bordetella pertussis toxin, vaccination, and clinical surveillance
by: Amnuay Kleebayoon, et al.
Published: (2023)

Pertussis, anti-Bordetella pertussis toxin, vaccination, and clinical surveillance
by: Amnuay Kleebayoon, et al.
Published: (2023)